Cart
sales@molnova.com
Glutaminyl Cyclase Inhibitor 1
CAS No. 2110449-60-8
Glutaminyl Cyclase Inhibitor 1( —— )
Catalog No. M32941 CAS No. 2110449-60-8
Glutaminyl Cyclase Inhibitor 1, a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM, can be utilized for studying neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 345 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 927 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlutaminyl Cyclase Inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlutaminyl Cyclase Inhibitor 1, a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM, can be utilized for studying neurological disorders.
-
DescriptionGlutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetGuanylate Cyclase
-
RecptorGuanylate cyclase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2110449-60-8
-
Formula Weight369.43
-
Molecular FormulaC21H24FN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (270.69 mM; Ultrasonic) DMSO : 83.33 mg/mL (225.56 mM; Ultrasonic )
-
SMILESCOc1ccc(cc1OC)-c1cccc(F)c1NCCCn1cnc(C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li M, et al. Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease. J Med Chem. 2017 Aug 10;60(15):6664-6677.?
molnova catalog
related products
-
Linaclotide
A potent and selective GC-C agonist (Ki=1.23-1.64 nM) that elicits pharmacological effects locally in the gastrointestinal tract.
-
MGV354
MGV354 is a novel potent, selective soluble Guanylate Cyclase (sGC) activator, lowers intraocular pressure (IOP) in preclinical models of glaucoma.
-
Vericiguat
Vericiguat (0.01 μM to 100 μM) stimulates recombinant sGC concentration dependently, by 1.7-fold to 57.6-fold.
